Heterologous COVID Booster: No Better Response in Kidney Patients
Kidney transplant recipients have similar outcomes with both heterologous and homologous third SARS-Cov-2 vaccine doses, a randomized clinical trial suggests.
Reuters Health Information
source https://www.medscape.com/viewarticle/965692?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/965692?src=rss
Comments
Post a Comment